182 related articles for article (PubMed ID: 8388011)
1. The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.
Winde G; Gumbinger HG; Osswald H; Kemper F; Bünte H
Int J Colorectal Dis; 1993 Mar; 8(1):13-7. PubMed ID: 8388011
[TBL] [Abstract][Full Text] [Related]
2. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months.
Winde G; Schmid KW; Schlegel W; Fischer R; Osswald H; Bünte H
Dis Colon Rectum; 1995 Aug; 38(8):813-30. PubMed ID: 7634976
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.
Winde G; Schmid KW; Brandt B; Müller O; Osswald H
Dis Colon Rectum; 1997 Oct; 40(10):1156-68; discussion 1168-9. PubMed ID: 9336110
[TBL] [Abstract][Full Text] [Related]
4. [Rectal carcinoma in a patient with familial adenomatous polyposis coli after colectomy with ileorectal anastomosis and consecutive chemoprevention with sulindac suppositories].
Utech M; Brüwer M; Buerger H; Tübergen D; Senninger N
Chirurg; 2002 Aug; 73(8):855-8. PubMed ID: 12425165
[TBL] [Abstract][Full Text] [Related]
5. Sulindac therapy for familial adenomatous polyposis after colectomy and ileorectal anastomosis.
Mäkelä JT; Laitinen S
Ann Chir Gynaecol; 1994; 83(3):265-7. PubMed ID: 7857074
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.
Cruz-Correa M; Hylind LM; Romans KE; Booker SV; Giardiello FM
Gastroenterology; 2002 Mar; 122(3):641-5. PubMed ID: 11874996
[TBL] [Abstract][Full Text] [Related]
7. Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis.
Heiskanen I; Järvinen HJ
Int J Colorectal Dis; 1997; 12(1):9-13. PubMed ID: 9112143
[TBL] [Abstract][Full Text] [Related]
8. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.
Spagnesi MT; Tonelli F; Dolara P; Caderni G; Valanzano R; Anastasi A; Bianchini F
Gastroenterology; 1994 Feb; 106(2):362-6. PubMed ID: 8299902
[TBL] [Abstract][Full Text] [Related]
9. [Role of suindac in the treatment of familial adenomatous polyposis coli].
Landauer S; Halimi C; Caulin C; Bergmann JF
Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer?
Tonelli F; Valanzano R; Messerini L; Ficari F
J Surg Oncol; 2000 May; 74(1):15-20. PubMed ID: 10861602
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy.
Niv Y; Fraser GM
Gastroenterology; 1994 Sep; 107(3):854-7. PubMed ID: 8076772
[TBL] [Abstract][Full Text] [Related]
13. Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
Labayle D; Fischer D; Vielh P; Drouhin F; Pariente A; Bories C; Duhamel O; Trousset M; Attali P
Gastroenterology; 1991 Sep; 101(3):635-9. PubMed ID: 1650315
[TBL] [Abstract][Full Text] [Related]
14. [Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study].
Müller A; Hürlimann R; Meyenberger C; Staub P; Kobler E; Ammann R
Schweiz Med Wochenschr; 1994 Apr; 124(15):651-4. PubMed ID: 8191270
[TBL] [Abstract][Full Text] [Related]
15. Sulindac therapy of colorectal polyps in familial adenomatous polyposis.
Tonelli F; Valanzano R; Dolara P
Dig Dis; 1994; 12(5):259-64. PubMed ID: 7882547
[TBL] [Abstract][Full Text] [Related]
16. Rectal cancer after prolonged sulindac chemoprevention. A case report.
Lynch HT; Thorson AG; Smyrk T
Cancer; 1995 Feb; 75(4):936-8. PubMed ID: 7842414
[TBL] [Abstract][Full Text] [Related]
17. [Rectal micropolyps after total colectomy in familial polyposis. Efficacy of sulindac].
Charneau J; D'Aubigny N; Burtin P; Person B; Boyer J
Gastroenterol Clin Biol; 1990; 14(2):153-7. PubMed ID: 2158470
[TBL] [Abstract][Full Text] [Related]
18. Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis.
Hirota C; Iida M; Aoyagi K; Matsumoto T; Tada S; Yao T; Fujishima M
Cancer; 1996 Oct; 78(8):1660-5. PubMed ID: 8859177
[TBL] [Abstract][Full Text] [Related]
19. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.
Giardiello FM; Offerhaus JA; Tersmette AC; Hylind LM; Krush AJ; Brensinger JD; Booker SV; Hamilton SR
Gut; 1996 Apr; 38(4):578-81. PubMed ID: 8707091
[TBL] [Abstract][Full Text] [Related]
20. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
Giardiello FM; Hamilton SR; Krush AJ; Piantadosi S; Hylind LM; Celano P; Booker SV; Robinson CR; Offerhaus GJ
N Engl J Med; 1993 May; 328(18):1313-6. PubMed ID: 8385741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
